Balancing analgesic efficacy with safety concerns in the older patient

作者: Paul Arnstein

DOI: 10.1016/J.PMN.2010.03.003

关键词: MedicineChronic painAffect (psychology)Intensive care medicinePhysical therapyMEDLINENursing assessmentDrugAnalgesicPopulationDrug class

摘要: The rapidly expanding number of aged Americans and the increasing prevalence persistent pain in older adults create an urgent need to unravel complexities chronic management this population. This requires health professionals understand both normal pathologic changes that occur within aging body mind, as well how those factors affect responses pain-relieving treatments. medical pharmacologic treatment for is often suboptimal, ranging from failing use analgesics patients with considerable exposing potentially life-threatening toxicities, overdoses, or drug interactions. Models safe effective approaches treating exist, but treatments must still be tailored each individual's needs. A growing array targeted therapies are available managing pain, yet two three trials different agents same class needed optimize because variability effects particular medications. Older tend more vulnerable side interactions than their younger counterparts, owing differences distribution, metabolism, elimination. review delineates these vulnerabilities informs clinicians strategies promote medications treat adults. goal paper was specific considerations balancing efficacy safety

参考文章(56)
L. Di Rienzo Businco, M. Lauriello, G. Coen Tirelli, M. D'emilia, A. Di Rienzo Businco, Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Acta Otorhinolaryngologica Italica. ,vol. 24, pp. 279- 283 ,(2004)
Judith A Paice, Rebecca Ferrini, How to initiate and monitor infusional lidocaine for severe and/or neuropathic pain. The journal of supportive oncology. ,vol. 2, pp. 90- 94 ,(2004)
, Pharmacological Management of Persistent Pain in Older Persons Journal of the American Geriatrics Society. ,vol. 57, pp. 1331- ,(2009) , 10.1111/J.1532-5415.2009.02376.X
Joseph T Hanlon, Sherrie L Aspinall, Todd P Semla, Steven D Weisbord, Linda F Fried, C Bernie Good, Michael J Fine, Roslyn A Stone, Mary Jo V Pugh, Michelle I Rossi, Steven M Handler, None, Consensus Guidelines for Oral Dosing of Primarily Renally Cleared Medications in Older Adults Journal of the American Geriatrics Society. ,vol. 57, pp. 335- 340 ,(2009) , 10.1111/J.1532-5415.2008.02098.X
Byron Cryer, Markus Goldschmiedt, Jan S. Redfern, Mark Feldman, Comparison of Salsalate and Aspirin on Mucosal Injury and Gastroduodenal Mucosal Prostaglandins Gastroenterology. ,vol. 99, pp. 1616- 1621 ,(1990) , 10.1016/0016-5085(90)90465-D
Philip J Wiffen, Henry J McQuay, Jayne Edwards, R Andrew Moore, Gabapentin for acute and chronic pain Cochrane Database of Systematic Reviews. ,vol. 2011, ,(2011) , 10.1002/14651858.CD005452.PUB2
Cyrus Cooper, Kelsey M Jordan, Topical NSAIDs in osteoarthritis. BMJ. ,vol. 329, pp. 304- 305 ,(2004) , 10.1136/BMJ.329.7461.304
Janyce F Rogers, Anne N Nafziger, Joseph S Bertino, Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs The American Journal of Medicine. ,vol. 113, pp. 746- 750 ,(2002) , 10.1016/S0002-9343(02)01363-3
Jason Lazarou, Bruce H. Pomeranz, Paul N. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA. ,vol. 279, pp. 1200- 1205 ,(1998) , 10.1001/JAMA.279.15.1200